BACE-1 inhibitors (Nanjing University of Chinese Medicine/Nanjing Medical University/China Pharmaceutical University)

N/A

Report date: 2025/03/14 18:11:22
NME

Base Information

Drug NameBACE-1 inhibitors (Nanjing University of Chinese Medicine/Nanjing Medical University/China Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase 1 inhibitors
TargetsBeta-secretase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing University Of Chinese Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Medical UniversityNanjing University Of Chinese MedicineChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A